Carmen García-De-Vicuña Manuel Díaz-Llopis David Salom Rosa Bou Jesus Díaz-Cascajosa Miguel Cordero-Coma Gabriela Ortega Norberto Ortego-Centeno Marta Suarez-De-Figueroa Juan Cruz-Martínez Alex Fonollosa Ricardo Blanco Ángel María García-Aparicio Jose M Benítez-Del-Castillo Jordi Antón
10.1155/2013/560632
Mediators Inflamm
2013;2013:560632.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24489444/
Antibodies, Monoclonal, Humanized / therapeutic use Antirheumatic Agents / therapeutic use Arthritis, Juvenile / drug therapy Uveitis / drug therapy
Antibodies, Monoclonal, Humanized / therapeutic use Antirheumatic Agents / therapeutic use Arthritis, Juvenile / drug therapy Uveitis / drug therapy Multicenter Study Adalimumab Adolescent Arthritis, Juvenile / complications Child Child, Preschool Female Humans Immunosuppressive Agents / therapeutic use Inflammation Male Patient Safety Prospective Studies Steroids / chemistry Steroids / therapeutic use Treatment Outcome Uveitis / complications Antibodies, Monoclonal, Humanized Antirheumatic Agents Immunosuppressive Agents Steroids Adalimumab
PMC3892756
24489444
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
2013